Cargando…

Schizophrenia risk loci from xMHC region were associated with antipsychotic response in chronic schizophrenic patients with persistent positive symptom

We examined whether common variants from the extended major histocompatibility complex (xMHC) region contribute to the response to antipsychotic drugs (APDs) in patients with schizophrenia with persistent psychosis. Subjects participated in a prospective longitudinal study of the effect of APDs on p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiang, Yoshikawa, Akane, Alliey-Rodriguez, Ney, Meltzer, Herbert Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898944/ https://www.ncbi.nlm.nih.gov/pubmed/35250027 http://dx.doi.org/10.1038/s41398-022-01854-9

Ejemplares similares

Evolution of symptoms with antipsychotic treatment in schizophrenic outpatients in Greece: the GRACE Study
por: Karadima, Dimitra, et al.
Publicado: (2010)

The Prevalence of Metabolic Syndrome in Schizophrenic Patients Using Antipsychotics
por: Ko, You-Kyung, et al.
Publicado: (2013)

Association of Serotonin(2c) Receptor Polymorphisms With Antipsychotic Drug Response in Schizophrenia
por: Li, Jiang, et al.
Publicado: (2019)

Thiol Disulfide Homeostasis in Schizophrenic Patients Using Atypical Antipsychotic Drugs
por: Dogan, Halef Okan, et al.
Publicado: (2018)

Effect of antipsychotic drugs and orthostatic hypotension on the risk of falling in schizophrenic patients
por: Ferinauli, Ferinauli, et al.
Publicado: (2021)

Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients
por: Suda, Akira, et al.
Publicado: (2018)

Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis
por: Millier, Aurelie, et al.
Publicado: (2011)

Genotype-phenotype Analysis of Paraoxonase 1 in Schizophrenic Patients Treated with Atypical Antipsychotics
por: Pavăl, Denis, et al.
Publicado: (2018)

Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review
por: García, Saínza, et al.
Publicado: (2016)

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2008)

Cognitive effects of atypical antipsychotic drugs in first-episode drug-naïve schizophrenic patients
por: Wang, Juan, et al.
Publicado: (2013)

Antipsychotic Medication in Schizophrenic Patients is Associated with Higher Risks of Developing Bone Fractures and Refractures
por: Kuo, Ching-Min, et al.
Publicado: (2020)

Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia
por: Ouyang, Houxian, et al.
Publicado: (2021)

The Major Histocompatibility Complex (MHC) in Schizophrenia: A Review
por: Mokhtari, Ryan, et al.
Publicado: (2016)

ACUTE SCHIZOPHRENIC EPISODES—ARE THEY SCHIZOPHRENIC?
por: Singh, Gurmeet, et al.
Publicado: (1981)

Before Schizophrenia: Schizophrenic Vulnerability in Developmental Age and Its Detection
por: Poletti, Michele, et al.
Publicado: (2021)

Changes in the prescription pattern of antipsychotics for schizophrenic outpatients after the implementation of a global budgeting program
por: Chiu, Hsien-Jane, et al.
Publicado: (2014)

Schizophrenia, Depressive Symptoms, and Antipsychotic Drug Treatment
por: Reynolds, Gavin P, et al.
Publicado: (2021)

Depressive symptoms in schizophrenic patients
por: Gozdzik-Zelazny, A, et al.
Publicado: (2011)

Identification of the primate-specific gene BTN3A2 as an additional schizophrenia risk gene in the MHC loci
por: Wu, Yong, et al.
Publicado: (2019)

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
por: Liu, Jiahong, et al.
Publicado: (2021)

Ethical and public policy challenges for pharmacogenomics
por: Gershon, Elliot S., et al.
Publicado: (2014)

The need for efficient long-term neuroleptic treatment in schizophrenic patients and the place of long acting injectable antipsychotics
por: Möller, Hans-Jurgen
Publicado: (2010)

An Epidemiological Study of Concomitant Use of Chinese Medicine and Antipsychotics in Schizophrenic Patients: Implication for Herb-Drug Interaction
por: Zhang, Zhang-Jin, et al.
Publicado: (2011)

Hospitalization rates and resource utilization of schizophrenic patients switched from oral antipsychotics to aripiprazole-depot in Germany
por: Potempa, Christoph, et al.
Publicado: (2018)

Comparative Study of the Effects of Atypical Antipsychotic Drugs on Plasma and Urine Biomarkers of Oxidative Stress in Schizophrenic Patients
por: Dietrich-Muszalska, Anna, et al.
Publicado: (2021)

The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)
por: Hanssens, Linda, et al.
Publicado: (2008)

Current perspectives on the intensity of natural selection of MHC loci
por: Yasukochi, Yoshiki, et al.
Publicado: (2013)

Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs
por: Liu-Seifert, Hong, et al.
Publicado: (2005)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Increased serum interleukin-1β and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication
por: Schmitt, Andrea, et al.
Publicado: (2005)

The effect of verbalization strategy on wisconsin card sorting test performance in schizophrenic patients receiving classical or atypical antipsychotics
por: Rossi, Alessandro, et al.
Publicado: (2006)

PM515. The association between serotonin receptor gene polymorphisms and hyperprolactinemia in antipsychotic drug-treated schizophrenic patients
por: Ivanova, Svetlana, et al.
Publicado: (2016)

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
por: Vaiman, Elena E., et al.
Publicado: (2021)

THE STABILITY OF SYMPTOMS AND SYNDROMES IN CHRONIC SCHIZOPHRENIC PATIENTS
por: Borde, Milind, et al.
Publicado: (1992)

An alternative approach to measuring treatment persistence with antipsychotic agents among patients with schizophrenia in the Veterans Health Administration
por: Ren, Xinhua S, et al.
Publicado: (2007)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008)

Comparative effectiveness of antipsychotic drugs in schizophrenia
por: Stroup, T. Scott, et al.
Publicado: (2000)

The heterogeneity of antipsychotic response in the treatment of schizophrenia
por: Case, M., et al.
Publicado: (2011)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_qv3vd0qq4frkhe3h0jej2pfns6